Your Post-Regulatory Market Access Partner
We bridge the gap between regulatory approval and real market success — across 26 markets, 4 industry sectors, and the full commercial lifecycle from registration to revenue.
We exist to make global market access predictable, scalable, and commercially successful — not just regulatory compliant.
Built to Solve a Real Problem
In 2019, Srini Sadhu — co-founder of Freyr Inc., a global regulatory leader — identified a fundamental gap in the life sciences industry. Companies were spending years and millions achieving regulatory approval, only to find themselves with no clear path to commercial success in new markets.
Distributors without accountability. Regulatory agencies with no commercial capability. Consultants who advised but never executed. The infrastructure for post-regulatory growth simply didn't exist in one place.
Taevas was built to solve that. Not just to register products — but to take them all the way from approval to revenue, across every major market globally, across every industry that matters in healthcare and consumer health.
Today, Taevas Lifesciences operates across 26 markets in Asia, the Americas, Europe, the Middle East, and Africa — with in-country teams, pre-qualified distributor networks, regulatory authority relationships, and full commercial infrastructure for the clients who trust us with their global growth.
From Vision to Global Scale
Founded in Hyderabad, India
Taevas established a vision to bridge the post-regulatory gap for global life sciences companies expanding into emerging markets.
First 10 Markets Live
Expanded into Southeast Asia and the GCC — establishing in-country regulatory and commercial teams across India, UAE, Malaysia, and Singapore.
100+ Brands Launched
Crossed the 100-brand milestone — spanning medical devices, pharmaceuticals, and consumer health across Asia, MENA, and Africa.
Americas & Europe Expansion
Entered Latin America and Eastern Europe — adding Brazil, Mexico, Colombia, Poland, and the UK to the market network.
26 Markets · 258+ Brands
Reached full global scale — 26 office markets, 400+ team members, 120+ countries served across all 4 industry sectors.
Technology-Led Growth Phase
Launched RegTrack, Market Connect, and Commerce Connect — proprietary platforms giving clients real-time visibility across their global market operations.
To make global market access predictable, scalable, and commercially successful for life sciences companies worldwide.
Every engagement is built around one outcome — your product in the hands of the right customers, generating revenue, in the markets that matter to you. Not just a certificate on your shelf.
To be the world's most trusted post-regulatory growth partner across emerging and established markets.
A world where any life sciences company — regardless of size — can enter any market with confidence, speed, and commercial clarity. That is the infrastructure Taevas is building.
Scale That Speaks for Itself
Our Values
Mission-Driven
Every engagement is built around measurable market success — real revenue, real distribution, real growth. Not just compliance checkboxes.
Long-Term Thinking
We build partnerships designed to grow for years. The right market entry takes time — we're here for the full journey, not just the registration.
Expert-Led
Every market team is led by in-country regulatory, clinical, and commercial specialists. We don't outsource what we do — we own it.
Speed & Precision
We combine agility with accuracy — running regulatory and commercial workstreams in parallel so you reach market months sooner without compromising compliance.
We Are Not Traditional Distributors
Most distributors move boxes. Taevas operates as an end-to-end distribution partner — covering the entire value chain from regulatory approvals and market entry through to import, warehousing, and final distribution to the clinic.
Regulatory Approvals — We Start Here, Not After
We manage CDSCO filings, multi-market submissions, Authorised Representative appointments, and technical file preparation — so by the time the approval lands, the commercial infrastructure is already in place.
Market Entry — Intelligence Before the First Rupee
We conduct device-specific market intelligence, regulatory pathway analysis, competitive mapping, and pricing research before any market commitment is made.
Import & Customs — The Entire Chain, Owned by Us
Import licences, customs clearance, CIF documentation, demo unit handling, and first-shipment logistics are managed entirely by Taevas.
Warehousing — In-Market, Not Just In-Transit
We operate in-market warehousing for device inventory, consumables, spare parts, and demo units — enabling faster replenishment and response.
Final Distribution — Last Mile to the Clinic
Taevas manages last-mile delivery, device installation, clinical training, and handover documentation for every installation.
Post-Market — The Chain Continues After the Sale
After installation, Taevas provides ongoing technical support, consumables replenishment, annual service and calibration, vigilance reporting, and re-registration management.
Traditional Distributor
Taevas Life Sciences
More About Our Company
Ready to Enter Your Next Market?
Tell us about your product and target markets. Our team will come back within 24 hours with a tailored market entry assessment — at no cost.